Hans Jörg Reinhardt

Former Chief Operating Officer at Novartis Corporation

Hans Jörg Reinhardt

Hans Jörg Reinhardt

Former Chief Operating Officer at Novartis Corporation

Career Highlights

Novartis Corporation
Novartis AG
Bayer HealthCare AG

RelSci Relationships


Number of Boards






Number of Awards


Contact Data
Trying to get in touch with Hans Jörg Reinhardt? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
RelSci Relationships are individuals Hans Jörg Reinhardt likely has professional access to. A relationship does not necessarily indicate a personal connection.

Head of the Novartis Vaccines & Diagnostics Division at Novartis Corporation

Relationship likelihood: Strong

Chief Financial Officer at Novartis AG

Relationship likelihood: Strong

Chief Executive Officer at Novartis AG

Relationship likelihood: Strong

Founder at Hookipa Pharma, Inc.

Relationship likelihood: Strong

Partner at Lenz & Staehelin AG

Relationship likelihood: Strong

Independent Deputy Chairman of the Supervisory Board at E.ON SE

Relationship likelihood: Strong

Chairman at Alcon Laboratories, Inc.

Relationship likelihood: Strong

Chairman at Sandoz Family Foundation

Relationship likelihood: Strong

Chief Executive Officer at Bayer AG

Relationship likelihood: Strong

Former Chairman & Chief Executive Officer at Young & Rubicam Brands, Inc.

Relationship likelihood: Strong

Paths to Hans Jörg Reinhardt
Potential Connections via
Relationship Science
Hans Jörg Reinhardt
Former Chief Operating Officer at Novartis Corporation
Doctorate, Pharmaceutical Sciences

Saarland University is a modern university within the Saar-Lor-Lux region – a dynamic part of Europe defined by the shared borders between Germany, France and Luxembourg. An international perspective has been a defining feature of Saarland University ever since it was established in cooperation with France in 1948. Today, 18.500 young people are studying in Saarbrücken and Homburg (faculty of medicine), 17 per cent of whom are international students. Located in a pleasant woodland setting, the university campus offers students and researchers a broad range of sporting and cultural activities, which together with the numerous cafés and restaurants make the campus an ideal place to relax between lectures or after work. And thanks to the high-speed ICE train link it takes only two hours to travel from Saarbrücken to Paris.

Career History
Chief Operating Officer
Tenure Unconfirmed

Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY.

Chief Executive Officer
2010 - 2013

Bayer HealthCare AG provides healthcare, agriculture, plastics and chemical products. It is an independent company comprising five divisions: Animal Health, Consumer Care, Diabetes Care, Diagnostics and Pharmaceuticals. The company covers the fields of animal health, genetically produced medicines, over the counter products, diagnostic products and prescription drugs. The company is headquartered in Leverkusen, Germany.

Chief Operating Officer
2006 - 2010

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Boards & Committees

Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA.

2012 - 2013

Lonza Group AG engages in the supply of pharmaceutical, healthcare, and life science products. It operates through the following segments: Pharma & Biotech; Specialty Ingredients; and Corporate. The Pharma & Biotech segment comprises development and manufacture of customized active pharmaceutical ingredients and biopharmaceuticals as well as formulation services and delivery systems. The Specialty Ingredients segment consists of two divisions, consumer health and consumer resources and protection. The Corporate segment includes corporate functions, such as finance and accounting, legal, communication, information technology, and human resources. The company was founded in 1897 and is headquartered in Basel, Switzerland.


Novartis Institute For Functional Genomics, Inc. serves as a bridge between basic science and preclinical drug discovery for Novartis’ global research organization. Its focus areas include oncology, autoimmunity, cardiovascular disease, diabetes, musculoskeletal disorders, and infectious disease. The company was founded in 1999 and is headquartered in San Diego, CA.

Chairman, Board of Trustees
Council Member
2010 - ?

Founded in 1968, the IFPMA is a global, non-profit, nongovernmental organization. With members across the globe and a secretariat based in Geneva, Switzerland, the IFPMA represents the research-based pharmaceutical industry, including the biotechnology and vaccine sectors.

Public Holdings
Restricted data only for RelSci Professional users.
Awards & Honors
Malaria No More International - Global Leadership Award
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Hans Jörg Reinhardt. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Hans Jörg Reinhardt's profile does not indicate a business or promotional relationship of any kind between RelSci and Hans Jörg Reinhardt.